This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaczmarek, F. S.
Right arrow Articles by Cronan, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaczmarek, F. S.
Right arrow Articles by Cronan, M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 2004, p. 1630-1639, Vol. 48, No. 5
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.5.1630-1639.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Genetic and Molecular Characterization of ß-Lactamase-Negative Ampicillin-Resistant Haemophilus influenzae with Unusually High Resistance to Ampicillin

Frank S. Kaczmarek,1 Thomas D. Gootz,1* Fadia Dib-Hajj,1 Wenchi Shang,1 Shawn Hallowell,2 and Melissa Cronan2

Department of Immunology and Infectious Disease,1 Department of Molecular Sciences, Pfizer Global Research and Development, Groton, Connecticut 063402

Received 19 August 2003/ Returned for modification 22 October 2003/ Accepted 9 January 2004

Previous studies with beta-lactamase-negative, ampicillin-resistant (BLNAR) Haemophilus influenzae from Japan, France, and North America indicate that mutations in ftsI encoding PBP3 confer ampicillin MICs of 1 to 4 µg/ml. Several BLNAR strains with ampicillin MICs of 4 to 16 µg/ml recently isolated from North America were studied. Pulsed-field gel electrophoresis identified 12 unique BLNAR strains; sequencing of their ftsI transpeptidase domains identified 1 group I and 11 group II mutants, as designated previously (K. Ubukata, Y. Shibasaki, K. Yamamoto, N. Chiba, K. Hasegawa, Y. Takeuchi, K. Sunakawa, M. Inoue, and M. Konno, Antimicrob. Agents Chemother. 45:1693-1699, 2001). Geometric mean ampicillin MICs for several clinical isolates were 8 to 10.56 µg/ml. Replacement of the ftsI gene in H. influenzae Rd with the intact ftsI from several clinical isolates resulted in integrants with typical BLNAR geometric mean ampicillin MICs of 1.7 to 2.2 µg/ml. Cloning and purification of His-tagged PBP3 from three clinical BLNAR strains showed significantly reduced Bocillin binding compared to that of PBP3 from strain Rd. Based on these data, changes in PBP3 alone could not account for the high ampicillin MICs observed for these BLNAR isolates. In an effort to determine the presence of additional mechanism(s) of ampicillin resistance, sequencing of the transpeptidase regions of pbp1a, -1b, and -2 was performed. While numerous changes were observed compared to the sequences from Rd, no consistent pattern correlating with high-level ampicillin resistance was apparent. Additional analysis of the resistant BLNAR strains revealed frame shift insertions in acrR for all four high-level, ampicillin-resistant isolates. acrR was intact for all eight low-level ampicillin-resistant and four ampicillin-susceptible strains tested. A knockout of acrB made in one clinical isolate (initial mean ampicillin MIC of 10.3 µg/ml) lowered the ampicillin MIC to 3.67 µg/ml, typical for BLNAR strains. These studies illustrate that BLNAR strains with high ampicillin MICs exist that have combined resistance mechanisms in PBP3 and in the AcrAB efflux pump.

* Corresponding author. Mailing address: Department of Antibiotics, Immunology and Cancer, MS 8118W-211, Pfizer Global Research and Development, Eastern Point Rd., Groton, CT 06340. Phone: (860) 715-6627. Fax: (860) 715-8162. E-mail: thomas_d_gootz{at}groton.pfizer.com.

Antimicrobial Agents and Chemotherapy, May 2004, p. 1630-1639, Vol. 48, No. 5
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.5.1630-1639.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Sevillano, D., Gimenez, M.-J., Cercenado, E., Cafini, F., Gene, A., Alou, L., Marco, F., Martinez-Martinez, L., Coronel, P., Aguilar, L. (2009). Genotypic versus Phenotypic Characterization, with Respect to {beta}-Lactam Susceptibility, of Haemophilus influenzae Isolates Exhibiting Decreased Susceptibility to {beta}-Lactam Resistance Markers. Antimicrob. Agents Chemother. 53: 267-270 [Abstract] [Full Text]  
  • Tristram, S. G., Pitout, M. J., Forward, K., Campbell, S., Nichols, S., Davidson, R. J. (2008). Characterization of extended-spectrum {beta}-lactamase-producing isolates of Haemophilus parainfluenzae. J Antimicrob Chemother 61: 509-514 [Abstract] [Full Text]  
  • Hotomi, M., Fujihara, K., Billal, D. S., Suzuki, K., Nishimura, T., Baba, S., Yamanaka, N. (2007). Genetic Characteristics and Clonal Dissemination of {beta}-Lactamase-Negative Ampicillin-Resistant Haemophilus influenzae Strains Isolated from the Upper Respiratory Tract of Patients in Japan. Antimicrob. Agents Chemother. 51: 3969-3976 [Abstract] [Full Text]  
  • Cerquetti, M., Giufre, M., Cardines, R., Mastrantonio, P. (2007). First Characterization of Heterogeneous Resistance to Imipenem in Invasive Nontypeable Haemophilus influenzae Isolates. Antimicrob. Agents Chemother. 51: 3155-3161 [Abstract] [Full Text]  
  • Garcia-Cobos, S., Campos, J., Lazaro, E., Roman, F., Cercenado, E., Garcia-Rey, C., Perez-Vazquez, M., Oteo, J., de Abajo, F. (2007). Ampicillin-Resistant Non-{beta}-Lactamase-Producing Haemophilus influenzae in Spain: Recent Emergence of Clonal Isolates with Increased Resistance to Cefotaxime and Cefixime. Antimicrob. Agents Chemother. 51: 2564-2573 [Abstract] [Full Text]  
  • Tristram, S., Jacobs, M. R., Appelbaum, P. C. (2007). Antimicrobial Resistance in Haemophilus influenzae. Clin. Microbiol. Rev. 20: 368-389 [Abstract] [Full Text]  
  • Perez-Vazquez, M., Roman, F., Garcia-Cobos, S., Campos, J. (2007). Fluoroquinolone Resistance in Haemophilus influenzae Is Associated with Hypermutability. Antimicrob. Agents Chemother. 51: 1566-1569 [Abstract] [Full Text]  
  • Kim, I.-S., Ki, C.-S., Kim, S., Oh, W. S., Peck, K. R., Song, J.-H., Lee, K., Lee, N. Y. (2007). Diversity of Ampicillin Resistance Genes and Antimicrobial Susceptibility Patterns in Haemophilus influenzae Strains Isolated in Korea. Antimicrob. Agents Chemother. 51: 453-460 [Abstract] [Full Text]  
  • Piddock, L. J. V. (2006). Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria. Clin. Microbiol. Rev. 19: 382-402 [Abstract] [Full Text]  
  • Osaki, Y., Sanbongi, Y., Ishikawa, M., Kataoka, H., Suzuki, T., Maeda, K., Ida, T. (2005). Genetic Approach To Study the Relationship between Penicillin-Binding Protein 3 Mutations and Haemophilus influenzae {beta}-Lactam Resistance by Using Site-Directed Mutagenesis and Gene Recombinants. Antimicrob. Agents Chemother. 49: 2834-2839 [Abstract] [Full Text]  
  • Poole, K. (2005). Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56: 20-51 [Abstract] [Full Text]  
  • Fluit, A. C., Florijn, A., Verhoef, J., Milatovic, D. (2005). Susceptibility of European {beta}-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003. J Antimicrob Chemother 56: 133-138 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»